Accelerate Diagnostics Inc. | Ownership
Companies that own Accelerate Diagnostics Inc.
Oracle Investment Management, Inc.
4,274,080
7.9%
-173,538
23.12%
06/30/2018
Credit Suisse Securities (USA) LLC (Broker)
3,480,603
6.43%
-398,605
0.11%
06/30/2018
Birchview Capital LP
2,183,795
4.04%
0
32.39%
06/30/2018
BlackRock Fund Advisors
1,599,999
2.96%
50,789
0%
06/30/2018
Credit Suisse Asset Management (Schweiz) AG
1,436,000
2.65%
1,141,000
0.06%
11/30/2017
The Vanguard Group, Inc.
1,227,593
2.27%
-83,106
0%
06/30/2018
Peter B. Cannell & Co., Inc.
1,115,239
2.06%
-1,200
0.98%
06/30/2018
ArrowMark Colorado Holdings LLC
688,829
1.27%
47,644
0.15%
06/30/2018
William Blair Investment Management LLC
645,247
1.19%
14,303
0.03%
06/30/2018
Next Century Growth Investors LLC
612,106
1.12%
80,369
1.72%
06/30/2018
| Address |
3950 South Country Club Road
Tucson Arizona 85714
United States
|
|
Employees
|
- |
| Website |
http://acceleratediagnostics.com |
| Updated |
07/08/2019 |
| Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ. |
